Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials

Blood Pressure

Volumn 1, Issue 2, 1992, Pages 113-119

  Hansson, Lennart ^a   Hedner, Thomas ^a   Dahlöf, Björn ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

End point evaluation; Intervention trial; Trial design

Indexed keywords

CAPTOPRIL; DIURETIC AGENT;

ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HUMAN; METHODOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

BLOOD PRESSURE; CAPTOPRIL; CARDIOVASCULAR DISEASES; DIURETICS; HUMANS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS;

EID: 0026911107     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.3109/08037059209077502     Document Type: Article

References (36)

1. Future directions for randomized trials of cardiovascular disease prevention in hypertensive patients
2. A utilitarian or deontological approach toward primary prevention of cardiovascular disease
3. STOP-Hypertension–Swedish Trial in Old Patients with Hypertension
4. STOP-Hypertension (Swedish Trial in Old Patients with Hypertension)
5. Medical Research Council trial of treatment of hypertension in older adults: principal results
6. Multiple risk factor intervention trial. Risk factor changes and mortality results
7. Heart study produces a surprise result
8. Studies of Left Ventricular Dysfunction (SOLVD)–Rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction
9. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
10. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease
11. The effectiveness of long-term treatment of malignant hypertension
12. Results of treatment in malignant hypertension. A 7-year experience in 94 cases
13. The effect of active drug treatment in severe hypertensive disease. An analysis of survival rates in 381 cases of combined treatment with various hypotensive agents
14. Benefits and potential harm of lowering high blood pressure
15. Treatment-induced blood pressure reduction and the risk of myocardial infarction
16. Editorial: How far should blood pressure be lowered? What is the role of the J-curve
17. Clinical Round Table: How much should blood pressure be lowered? The problem of the J-shaped curve
18. MRC trial of treatment of mild hypertension: principal results
19. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressure averaging 115 through 129 mmHg
20. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg
21. Editorial. Tribulations for clinical trials. Poor recruitment is hampering research
22. STOP-Hypertension–preliminary communication from the pilot study of the Swedish Trial in Old Patients with Hypertension
23. Breast cancer therapy: exercising all our options
24. Treating mild hypertension. Agreement from the large trials
25. The 1988 report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure
26. The 1989 guidelines for the management of mild hypertension. Memorandum from a WHO/ISH meeting
27. Editorial. Randomisation: essential for reducing bias
28. Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: The International Prospective Primary Prevention Study in Hypertension (IPPPSH)
29. Editorial. Patient compliance in therapeutic trials
30. The effect of differing compliance distribution on the planning and statistical analysis of therapeutic trials
31. Clinical biostatistics XXX. Biostatistical problems in “compliance bias”
32. Why do we need some large sample randomized trials
33. The BBB Study: A prospective randomized study of intensified antihypertensive treatment
34. for the BBB Study Group. Reduction in blood pressure and adverse effects in the BBB Study. (Abstract)
35. The Captopril Prevention Project: A prospective intervention trial of angiotensin converting enzyme inhibition in the treatment of hypertension
36. The Second Swedish Trial in Old Patients with Hypertension (STOP-Hypertension II): Evaluating established versus new therapeutic regimens in the treatment of hypertension